Kellele me abiks olemeMeie teadusTootedTulemused
Logi sisseKüsiSekveneeri oma genoom↗
Tunnused
Geeniga SMARCB1 seotud tunnused
SWI/SNF related BAF chromatin remodeling complex subunit B1
Inimese fenotüübi ontoloogia seostab geeniga SMARCB1 185 tunnust kehasüsteemide kaupa: omadusi, mida täheldatakse inimestel, kellel on selle geeni üks haruldastest seisunditest.
Kellele me abiks olemeMeie teadusTootedTulemused
Logi sisseKüsiSekveneeri oma genoom↗
Kellele me abiks olemeMeie teadusTootedTulemused
Logi sisseKüsiSekveneeri oma genoom↗
Abnormality of the nervous system
Abnormality of head or neck
Abnormality of the endocrine system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Decreased circulating ACTH concentration | Sageli (30–79%) |
| Decreased circulating follicle stimulating hormone concentration | Sageli (30–79%) |
| Decreased circulating luteinizing hormone level | Sageli (30–79%) |
| Decreased serum estradiol | Sageli (30–79%) |
| Decreased serum testosterone level | Sageli (30–79%) |
| Hypogonadotropic hypogonadism | Sageli (30–79%) |
| Increased circulating prolactin concentration | Sageli (30–79%) |
| Low blood cortisol level | Sageli (30–79%) |
| Low thyroid gland function due to abnormal pituitary gland | Sageli (30–79%) |
| Secondary growth hormone deficiency | Sageli (30–79%) |
| Abnormal hypothalamus physiology | Mõnikord (5–29%) |
| Enlarged pituitary gland | Mõnikord (5–29%) |
| Hypothalamic hypothyroidism | Mõnikord (5–29%) |
| Neoplasm of the anterior pituitary | Mõnikord (5–29%) |
| Reduced circulating prolactin concentration | Mõnikord (5–29%) |
| Neoplasm of the posterior pituitary | Harva (1–4%) |
| Papillary thyroid carcinoma | Harva (1–4%) |
Abnormality of the eye
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Bitemporal hemianopia | Sageli (30–79%) |
| Cross-eyed | Sageli (30–79%) |
| Drooping upper eyelid | Sageli (30–79%) |
| Visual impairment | Sageli (30–79%) |
| Abnormal kinetic perimetry test | Mõnikord (5–29%) |
| Close sighted | Mõnikord (5–29%) |
| Clouding of the lens of the eye | Mõnikord (5–29%) |
| Eye muscle paralysis | Mõnikord (5–29%) |
| Oculomotor nerve palsy | Mõnikord (5–29%) |
| Papilledema | Mõnikord (5–29%) |
| Slow decrease in sharpness of vision | Mõnikord (5–29%) |
| Visual acuity test abnormality | Mõnikord (5–29%) |
| Weak extraocular muscles | Mõnikord (5–29%) |
| Blindness | Harva (1–4%) |
| Bulging eye | Harva (1–4%) |
Abnormality of the musculoskeletal system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Delayed bone maturation | Alati |
| Low muscle tone | Alati |
| Decreased muscle tone in infant | Sageli (30–79%) |
| Double-Jointed | Sageli (30–79%) |
| Limitation of joint mobility | Sageli (30–79%) |
| Muscle weakness | Sageli (30–79%) |
| Scoliosis | Sageli (30–79%) |
| Abnormal deposits of calcium in the brain | Mõnikord (5–29%) |
| Central diaphragmatic hernia | Mõnikord (5–29%) |
| Fatty lump | Mõnikord (5–29%) |
| Functional motor deficit | Mõnikord (5–29%) |
| Hernia | Mõnikord (5–29%) |
| Back pain | Harva (1–4%) |
Abnormality of the cardiovascular system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormality of the heart | Sageli (30–79%) |
| An opening in the wall separating the top two chambers of the heart | Mõnikord (5–29%) |
| Hole in heart wall separating two lower heart chambers | Mõnikord (5–29%) |
| Lumbosacral hemangioma | Mõnikord (5–29%) |
| Patent ductus arteriosus | Mõnikord (5–29%) |
| Tetralogy of Fallot | Mõnikord (5–29%) |
| Fainting spell | Harva (1–4%) |
| Abnormal cardiovascular system morphology | Pole registreeritud |
Abnormality of the genitourinary system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormal absence of menstruation | Sageli (30–79%) |
| Abnormality of the genitourinary system | Sageli (30–79%) |
| Difficulty getting a full erection | Sageli (30–79%) |
| Undescended testes | Sageli (30–79%) |
| Horseshoe kidney | Mõnikord (5–29%) |
| Hypospadias | Mõnikord (5–29%) |
| Uterine leiomyoma | Mõnikord (5–29%) |
| Loss of bladder control | Harva (1–4%) |
Abnormality of the integument
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Peripheral schwannoma | Alati |
| Excessive hair growth | Väga sageli (80–99%) |
| Small nail | Väga sageli (80–99%) |
| Excessive hairiness | Sageli (30–79%) |
| Small fifth toenail | Sageli (30–79%) |
| Underdeveloped fifth fingernail | Sageli (30–79%) |
| Neurofibroma | Mõnikord (5–29%) |
| Skin cancer | Harva (1–4%) |
Abnormality of limbs
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Short outermost little finger bone | Alati |
| Curvature of digit | Sageli (30–79%) |
| Short 5th finger | Sageli (30–79%) |
| Decreased arm strength | Mõnikord (5–29%) |
| Lower limb muscle weakness | Mõnikord (5–29%) |
Abnormality of the digestive system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Feeding difficulties | Alati |
| Poor suck | Alati |
| Nausea and vomiting | Väga sageli (80–99%) |
| Inguinal hernia | Sageli (30–79%) |
| Hepatoblastoma | Harva (1–4%) |
Growth abnormality
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Short stature | Alati |
| Growth delay | Sageli (30–79%) |
| Growth delay as children | Sageli (30–79%) |
| Prenatal growth deficiency | Sageli (30–79%) |
| Obesity | Mõnikord (5–29%) |
Abnormality of the ear
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Hearing impairment | Sageli (30–79%) |
| Ringing in ears | Mõnikord (5–29%) |
| Ear pain | Harva (1–4%) |
| Bilateral vestibular schwannoma | Pole registreeritud |
Abnormal cellular phenotype
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Chromosomal breakage induced by ionizing radiation | Väga sageli (80–99%) |
| Increased sensitivity to ionizing radiation | Väga sageli (80–99%) |
Abnormality of the immune system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Aspiration pneumonia | Sageli (30–79%) |
| Recurrent infections | Sageli (30–79%) |
Abnormality of the respiratory system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormality on pulmonary function testing | Harva (1–4%) |
| Progressive pulmonary function impairment | Harva (1–4%) |
Abnormal tissue mass
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormal tissue mass | Mõnikord (5–29%) |
Abnormality of blood and blood-forming tissues
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Bleeding in brain | Harva (1–4%) |
Abnormality of the thoracic cavity
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormal mediastinum morphology | Harva (1–4%) |
Abnormality of the voice
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Weak voice | Harva (1–4%) |
Constitutional symptom
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Pain | Sageli (30–79%) |
Kui sageli see esineb geenist tulenevate seisunditega inimeste seas, kõige sagedamini nende kõigi seas, nagu on märgitud Inimese fenotüübi ontoloogias. Need lehed kirjeldavad tunnuseid ja nende taga olevaid uuringuid; need ei ole diagnoos ning sümptomite kohta tuleks küsida arstilt või geneetilt nõustajalt.
Allikas
- Inimese fenotüübi ontoloogia, versioon 2026-09-01: geeniga SMARCB1 seotud tunnused ja iga tunnuse esinemissagedus. Lisateavet leiate aadressilt hpo.jax.org.
Kellele me abiks olemeMeie teadusTootedTulemused
Logi sisseKüsiSekveneeri oma genoom↗
Üks test. Vastused kogu eluks.
Alates 449 $Tasuta kohaletoimetamine · Tulemused 6–8 nädala pärast